Dr. Henry Miller joins the Lars Larson Show to talk about President Donald Trump's coronavirus diagnosis. Miller talks about how the President and his staff handled health safety procedures and ways he could have been exposed to COVID-19. Lars Larson National Podcast · Lars Larson National Podcast 10-02-20...
Ex-FDA Doc: Agency Suffering ‘Unprecedented’ Loss of Trust By Adam Smith Early this year, when the novel coronavirus that was devastating China began to spread to other countries, hope came in the promise of a quick vaccine, one that doctors and scientists bet could be created in just a year and a half if all went well. But some were cautious, such as Dr. Henry I. Miller, who for many years worked at the Food and Drug Administration and who was a founding director of the agency's...
Title: Big Pharma Backs Joe Biden, But People Don't Think He'll Fix Drug Pricing By Darragh Roche Former Vice President Joe Biden is winning the race for donations from Big Pharma but experts and industry stakeholders doubt his plans will successfully lower drug prices or address underlying issues in the industry. The pharmaceuticals and health products industry has donated more than $5.9 million to Biden's presidential campaign, according to OpenSecrets.org, a site run by the Center for Responsive Politics, which tracks political donations....
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, the current drug concession system is raising patient costs,” write the briefs authors, Wayne Winegarden and Robert Popovian. “Mandating that all drug concessions must benefit the patients purchasing the medicines is a...
Politicians continue perpetuating the myth that drug price controls are the necessary cure for the country’s healthcare affordability problems. Whether it is Speaker Pelosi’s “The Lower Drug Costs Now Act”, or President Trump’s Most Favored Nation (MFN) and Drug Importation Executive Orders, these policies are destined to fail. Undoubtedly, there are problems with the drug pricing system that harms patients, and reforms that fix these problems are urgently needed. But, adopting the ill-fated price controls that are implemented in other industrialized countries will create new...
Dr. Henry Miller and Lars Larson review the many confusing statements that have come out of the U.S. Center for Disease Control, or CDC, since the start of the coronavirus pandemic. Miller and Larson talk about the recent development that the CDC released around COVID-19 being transmitted in the air, but then walking back that information. Miller also explains a new standard being introduced by the U.S. Food and Drug Administration, FDA, that could change the timeline for approving a COVID-19...
PRI Senor Fellow Dr. Henry Miller joins the John Batchelor Show for a two-part discussion on what can go wrong with a November vaccine for the coronavirus. Miller talks about how safe a vaccine would be this fall and discrepancies between comments from Dr. Anthony Fauci and other federal experts, noting that more data is needed from the testing and clinical trials. Miller also talks about the consistency needed to produce and distribute the vaccine and how the vaccine should...
There is widespread anticipation of the availability of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. Some four dozen vaccines, made with a variety of technology platforms, are now in clinical trials; nine are in large-scale safety/efficacy testing. Several of the more promising development programs have been accelerated by a White House crash program, “Operation Warp Speed,” which was launched in May. It was no secret that there would be intense pressure...
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted against the Democratic platform because it didn’t call for a federal takeover of the country’s health insurance system. But don’t be fooled. This intraparty squabble is more a matter of style than...
Dr. Henry Miller and Lars Larson talk about who could be eligible for an early vaccine and what data could tell us about how effective the vaccine will be on different age groups. Miller also talks about having insufficient data on vaccine clinical testing for seniors or those more at risk of COVID-19 due to those not involved in the study and sheltering at home. Miller and Larson also discuss concerns from health experts like Dr. Anthony Fauci about the coming...
President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president and his son-in-law applied their flawed logic consistently, then there is an even greater economic disparity that requires fixing. People living in Manhattan or San Francisco are paying more than other...
By: Henry Miller, M.S., M.D. and Andrew Fillat Recently, we co-authored an article about the thorny issues surrounding who would get access to the earliest doses of the COVID-19 vaccine. As we discussed, there are many possible options for setting priorities in terms of who should be vaccinated first. One obvious solution one would be to prioritize the people who are instrumental in mitigating the pandemic, with front-line medical personnel and staff at long-term care facilities going to the head of the line....
Pacific Research Institute senior fellow and economist Dr. Wayne Winegarden talks free market energy, California rolling power blackouts, and optimistic solutions to energy policy on The Roth Effect with Carol Roth. Winegarden also discusses his recent studies that challenge green energy, fracking, electric vehicles, and more. [embed]https://mp3.ricochet.com/2020/09/Roth_Effect_66.mp3[/embed]...
Title: Here’s what you need to know about clinical trials as drug makers push forward with coronavirus vaccine studies By: Jaimy Lee Whether you’re new to investing in pharmaceutical or biotechnology companies or simply paying close attention to the race to develop a COVID-19 vaccine, questions may have occurred about how clinical trials work — here’s what you need to know to understand the process. The first thing is that we’ve never seen vaccines developed as quickly as what is happening right now....
Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that a state-run generics firm would provide additional competition in the drug market and lead to lower prices. But that promise is empty. Generic drugs can’t get much cheaper. Setting up a...
Dr. Henry Miller and Lars Larson talk about the latest in progress in the search for a vaccine for the coronavirus pandemic, including the recent news that AstraZeneca has paused their third-stage clinical trial for a COVID-19 vaccine due to an illness to a participant. Miller talks about how the review process works when it comes to assessing the safety of a vaccine in the clinical trial phase. Dr. Miller's segment begins at the 47:00-minute mark. Lars Larson National Podcast · Lars...
If you’ve ever had a medical procedure and received a large bill from your hospital because, unknown to you, one of your doctors was not in your insurance network – that’s the subject of this podcast. On "Next Round," PRI senior fellow Wayne Winegarden discusses his recently released study on “Surprise Medical Billing.” He explains how it happens, why it happens, and the reforms that could prevent it. https://youtu.be/G4BvoVHT4so...
There is widespread anticipation of the availability of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. It was hardly a secret that there would be intense pressure on the FDA from a White House desperate for good news to provide an “October Surprise” in the form of a vaccine approval before...
There is widespread anticipation of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. About four dozen, made with a variety of technology platforms, are now in clinical trials, nine in large-scale safety/efficacy testing. Vaccines have also assumed unprecedented political importance. The Washington Post reported on Sunday: “President Trump is so fixated on finding a vaccine for the novel coronavirus that in meetings about the U.S. pandemic response, little else captures his attention, according to administration...
Title: AB 72 brief analyzes impact of medical billing reform law that's had bad consequences for patients and practitioners By Sarah Downey, Northern California Record A new policy brief about the impact of California AB 72 finds that the law – designed to alleviate surprise medical billing – while well-intentioned also has unintended consequences that have increased medical costs and affected quality of care. The Pacific Research Institute (PRI) brief, “The Menace of Medical Rate Setting: The Case of California’s AB 72,” is...